Clinical Trial Update: Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of cisplatin, paclitaxel, and everolimus in patients with metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED